Xiangqian Zhao

Fujian Key Laboratory Of Innate Immune Biology
Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation.

Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation.

Journal: Virulence

Published: September 04, 2026

Limitations of CAR-T-Cell Therapy in Hematologic Malignancies: Focusing on Antigen Escape and T-Cell Dysfunction.

Limitations of CAR-T-Cell Therapy in Hematologic Malignancies: Focusing on Antigen Escape and T-Cell Dysfunction.

Journal: International journal of molecular sciences

Published: September 01, 2025

Correction: Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Correction: Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Journal: Frontiers in immunology

Published: July 23, 2025

CRISPR-Mediated Viral Gene Knock-In for Studying Viral-Host Interactions.

CRISPR-Mediated Viral Gene Knock-In for Studying Viral-Host Interactions.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 14, 2025

Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer.

Journal: Frontiers in immunology

Published: January 16, 2025

Generation and characterization of 7DC-DM1: a non-cleavable CD47-targeting antibody-drug conjugates with antitumor effects.

Generation and characterization of 7DC-DM1: a non-cleavable CD47-targeting antibody-drug conjugates with antitumor effects.

Journal: International journal of biological macromolecules

Published: November 06, 2024

CRISPR-Mediated Construction of Gene-Knockout Mice for Investigating Antiviral Innate Immunity.

CRISPR-Mediated Construction of Gene-Knockout Mice for Investigating Antiviral Innate Immunity.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 27, 2024

IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy.

IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy.

Journal: Journal of translational medicine

Published: August 25, 2024

Strengthening Effect of Thalidomide Combined with an Anti-PD1 Antibody on Enhancing Immunity for Lung Cancer Therapy.

Strengthening Effect of Thalidomide Combined with an Anti-PD1 Antibody on Enhancing Immunity for Lung Cancer Therapy.

Journal: Current pharmaceutical biotechnology

Published: April 30, 2024

A modified HSV-1 oncolytic virus reconciles antiviral and antitumor immunity via promoting IFNβ expression and inhibiting PKR.

A modified HSV-1 oncolytic virus reconciles antiviral and antitumor immunity via promoting IFNβ expression and inhibiting PKR.

Journal: International journal of biological macromolecules

Published: February 02, 2024

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors.

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors.

Journal: Cellular and molecular life sciences : CMLS

Published: December 22, 2023

The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles.

The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles.

Journal: International journal of molecular sciences

Published: January 04, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026